An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 218756
Company: SOLARIS PHARMA CORP

Products on ANDA 218756

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NITROGLYCERIN	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 218756

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/18/2025	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 218756

NITROGLYCERIN

OINTMENT;INTRA-ANAL; 0.4%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NITROGLYCERIN	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	No	AB	216103	COSETTE
NITROGLYCERIN	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	No	AB	216452	ENCUBE
NITROGLYCERIN	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	No	AB	218756	SOLARIS PHARMA CORP
NITROGLYCERIN	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	No	AB	212222	TP ANDA HOLDINGS
RECTIV	NITROGLYCERIN	0.4%	OINTMENT;INTRA-ANAL	Prescription	Yes	AB	021359	ABBVIE

Top